Posted innews Specialties Urology
How Men Around the World Enhance Their Sexual Abilities
Exploring diverse dietary habits of men from different cultures aimed at enhancing sexual health and performance.
Boosting Men’s Sexual Health Naturally: Essential Nutritional Strategies for Strength and Vitality
Discover how targeted nutrition—focusing on seafood, proteins, fats, vitamins, and nourishing foods—can enhance men's sexual health and vitality by supporting sperm quality, hormone balance, and overall wellness.
Unlocking the Secrets to Sexual Climax: The Essential Role of Foreplay and Intimate Connection
Explore scientifically grounded insights and practical techniques on how foreplay and mutual understanding enhance sexual climax and satisfaction for couples.
SGLT2 Inhibitors Lower Mortality Risk Post-UTI in Diabetes
Recent research indicates that patients with type 2 diabetes who use SGLT2 inhibitors after a urinary tract infection have a lower mortality risk compared to those using DPP-4 inhibitors.
Posted inClinical Updates news Specialties Urology
Teflon (PTFE) Microplastics Impair Sperm Formation
A multi‑institutional Advanced Science study links PTFE microplastic bioaccumulation to impaired spermatogenesis via SKAP2 suppression and shows that SKAP2‑rich milk‑derived extracellular vesicles restore sperm structure and function in human samples and mouse models.
Posted inClinical Updates news Pediatrics Specialties Urology
Ureteroscopy vs Shockwave Lithotripsy in Children and Adolescents: A Large Multicenter Nonrandomized Trial Challenges Current Practice
In 1,142 patients aged 8–21, a nonrandomized multicenter trial found no clinically meaningful difference in 6-week sonographic stone clearance between ureteroscopy and shockwave lithotripsy; SWL was associated with less pain and fewer missed school/workdays.
Posted inClinical Updates news Oncology Specialties Urology
KEYNOTE-991: Pembrolizumab Does Not Improve Outcomes in Metastatic Hormone-Sensitive Prostate Cancer—A Phase III Clinical Trial Analysis
KEYNOTE-991 shows pembrolizumab does not improve progression-free or overall survival for mHSPC, and increases serious adverse events when added to enzalutamide and ADT.
Posted inMedical News news Specialties Urology
Optimizing Male Fertility: The Science Behind Abstinence and Sperm Quality
Discover the optimal abstinence period for male fertility and learn how lifestyle choices impact sperm quality.
Posted innews Specialties Urology
Understanding and Improving Ejaculation Control: Strategies for Men’s Sexual Health
Ejaculation control is a common concern for men, impacting confidence and relationships. This article explores causes, solutions, and practical strategies for improvement.
Posted innews Specialties Urology
Three Types of Exercise That Can Boost Men’s Sexual Health: The Science Behind Stronger Performance
Discover how aerobic exercise, strength training, and pelvic floor exercises can enhance men's sexual function, supported by clinical evidence and expert advice.
Posted innews Specialties Urology
Unlocking the Benefits of Squats for Male Sexual Health
Explore the scientific principles and practical strategies of using squats to boost male sexual health, supported by research and expert insights.
Posted inClinical Updates Oncology Specialties Urology
PARP inhibitors shine: How the TALAPRO-2 trial is changing the landscape of prostate cancer with precision medicine
Treatment for advanced prostate cancer has advanced significantly in the past decade, but metastatic castration-resistant…
Posted inClinical Updates news Specialties Urology
Testosterone Therapy in Middle-Aged and Older Men with Hypogonadism: Balancing Clinical Benefits and Risks
Testosterone therapy offers modest benefits for sexual function, anemia, and bone health in older men with hypogonadism, but increases risks of venous thromboembolism, fractures, and arrhythmias. Careful patient selection and individualized risk-benefit assessment are essential.
Posted innews Specialties Urology
Symptoms of Pelvic Inflammatory Disease: The Three Most Distinctive Signs
Pelvic inflammatory disease (PID) commonly presents with lower abdominal pain, abnormal vaginal discharge, and systemic symptoms like fever. Early recognition and treatment are vital to prevent complications.
Posted innews Specialties Urology
Serenoa repens (Saw Palmetto) in Benign Prostatic Hyperplasia: Clinical Evidence and Implications for Practice
Recent high-quality evidence indicates that Serenoa repens provides little to no benefit for lower urinary tract symptoms due to benign prostatic enlargement compared to placebo.
Posted innews Specialties Urology
Can Kidney Stone Sufferers Safely Take Calcium Supplements? Unveiling the Truth
Exploring the relationship between calcium intake and kidney stones, this article provides evidence-based guidance for patients and health professionals.
Posted inClinical Updates news Oncology Specialties Urology
Enfortumab Vedotin Plus Pembrolizumab vs Chemotherapy in Untreated Locally Advanced or Metastatic Urothelial Cancer: Patient-Reported Outcomes from the EV-302 Phase 3 Study
The EV-302 trial shows enfortumab vedotin plus pembrolizumab improves survival and quality of life over platinum-based chemotherapy in untreated advanced urothelial cancer patients.
Posted inClinical Updates news Oncology Radiology Specialties Urology
Early Toxicity Comparison of Moderately Hypofractionated Radiotherapy and Stereotactic Body Radiotherapy in Prostate Cancer: Insights from the PACE-C Trial
The PACE-C phase 3 trial shows that stereotactic body radiotherapy (SBRT) and moderately hypofractionated radiotherapy (MHRT) have comparable early toxicity profiles in intermediate- and high-risk prostate cancer patients.
Posted inClinical Updates news Oncology Specialties Urology
Cabozantinib Plus Atezolizumab in mCRPC: CONTACT-02 Phase 3 Final Results and Clinical Implications
The CONTACT-02 phase 3 trial shows cabozantinib plus atezolizumab improves progression-free survival but not overall survival in advanced mCRPC post-ARPI, offering a novel non-androgen receptor-based option.
Individualised Versus Standard 10-Day Antibiotic Therapy in Pediatric Febrile UTI: Insights from the INDI-UTI Trial
A Danish multicentre trial found individualised, shorter antibiotic regimens for febrile pediatric UTIs reduce overall antibiotic exposure and adverse events, but with a modestly higher recurrence risk compared to standard 10-day treatment.